Sunstone Medical
Clinical trials sponsored by Sunstone Medical, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could MDMA help cancer patients and their loved ones cope better? Results expected Oct 2026 (estimated)
- Could MDMA help veterans heal from PTSD? new study investigates Results expected Apr 2027 (estimated)
- Magic mushroom compound tested for Cancer-Related depression Results expected Apr 2027 (estimated)
-
Could MDMA help veterans heal from PTSD? new study investigates
Symptom relief Recruiting nowThis study tests whether a drug called MDMA, given alongside therapy, can help veterans with PTSD feel better. About 52 veterans will receive a dose of MDMA during therapy sessions, either alone or in a group. The goal is to see if this approach is safe and reduces PTSD symptoms.
Phase 2 • Sponsor: Sunstone Medical • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Magic mushroom therapy could ease PTSD in sexual assault survivors
Symptom relief Recruiting nowThis study tests whether a drug called psilocybin (the active ingredient in magic mushrooms) combined with therapy can help women with PTSD from sexual assault. About 70 women will receive the treatment in a controlled setting. The goal is to see if it reduces PTSD symptoms and i…
Phase 2 • Sponsor: Sunstone Medical • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could MDMA help cancer patients and their loved ones cope better?
Symptom relief Recruiting nowThis study tests whether MDMA (the drug in ecstasy) combined with talk therapy can help cancer patients and their partners who are struggling with adjustment disorder—a condition where they have trouble coping with the cancer diagnosis. Twenty participants (10 patient-partner pai…
Phase 2 • Sponsor: Sunstone Medical • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC